SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,419,000 | -9.4% | 67,899 | +7.6% | 0.10% | -14.3% |
| Q2 2018 | $3,775,000 | +121.0% | 63,075 | +69.2% | 0.11% | +111.3% |
| Q1 2018 | $1,708,000 | +27.0% | 37,289 | +10.4% | 0.05% | +26.2% |
| Q4 2017 | $1,345,000 | +3.1% | 33,764 | +3.5% | 0.04% | 0.0% |
| Q3 2017 | $1,305,000 | -7.9% | 32,632 | -0.8% | 0.04% | -10.6% |
| Q2 2017 | $1,417,000 | +57.4% | 32,879 | +14.3% | 0.05% | +51.6% |
| Q1 2017 | $900,000 | – | 28,765 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |